Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
13,017
datasets available to search
ShareScore release 0.9.0
Dataset results
13,017 results for “Positionning”
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT01723774. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC
ClinicalTrials.gov study NCT01945021. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
ClinicalTrials.gov study NCT01934894. IPD Sharing: Not stated. Countries: 1. Publications: 9.
A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT01940497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Ca
ClinicalTrials.gov study NCT04214288. IPD Sharing: YES. Countries: 16. Publications: 2.
Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
ClinicalTrials.gov study NCT00275509. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT00915018. IPD Sharing: Not stated. Countries: 35. Publications: 1.
Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
ClinicalTrials.gov study NCT03515551. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers
ClinicalTrials.gov study NCT01524978. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
ClinicalTrials.gov study NCT02293954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss
ClinicalTrials.gov study NCT05488574. IPD Sharing: NO. Countries: 1. Publications: 5.
AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients
ClinicalTrials.gov study NCT00890825. IPD Sharing: Not stated. Countries: 12. Publications: 2.
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
ClinicalTrials.gov study NCT05562583. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
ClinicalTrials.gov study NCT00390793. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
ClinicalTrials.gov study NCT00089752. IPD Sharing: YES. Countries: 2. Publications: 2.
Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants
ClinicalTrials.gov study NCT06076694. IPD Sharing: NO. Countries: 1. Publications: 1.
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02129556. IPD Sharing: Not stated. Countries: 5. Publications: 5.
Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer
ClinicalTrials.gov study NCT02366130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03262935. IPD Sharing: NO. Countries: 11. Publications: 1.
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00494442. IPD Sharing: Not stated. Countries: 5. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.